Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2019 | Story Xolisa Mnukwa
Esihle Mhluzi
“As a small-town girl from the Eastern Cape, the only thing I have ever inculcated within myself was the validity of my dreams.” – Esihle Mhluzi #WomenOfKovsies

“I was determined to be more than just ‘the girl on crutches’; I wanted my brilliance to speak for itself,” said Mhluzi in response to the question, “What inspires you?”

As part of its #WomenOfKovsies campaign for 2019, which profiles inspiring women on our three campuses, the UFS celebrates LLB Law student, Esihle Mhluzi. She has served on a few SRC executive committees, UFS women empowerment organisations, and is also the Chairperson of the Universal Access Council for 2019.

Mhluzi says she was ‘graced’ with a physical impairment at the age of 10. She uses the word ‘grace’, because she appreciates what it means for the world and for women today to be in a body like hers. She also recently started pursuing a career in modelling, forming part of the top five of Miss Capable SA, and is currently one of the finalists for Face of Free State Fashion Week 2019.

Mhluzi explains that her decision to pursue modelling was propelled by her rationale to infiltrate spaces that were not necessarily designed for girls who ‘looked’ like her. She found that society seldom embraces and ‘accepts’ young women of her calibre on prestigious modelling platforms. Her mission is to ensure that she becomes the voice for the many women she represents. “With my additional modelling career path, I envisage us – women – running towards victory hand in hand,” said Mhluzi.

For her, being a woman means “being empty of yourself in order to create a better life for your fellow sister”. She believes a woman’s purpose is to extend grace and create safe spaces for each other to exist, heal, overcome, and conquer the world together, being in control of your narrative, and starving the noise. “Being a woman means having the audacity to be unapologetic in your brilliance,” she enthuses.

Mhluzi, who describes herself as ‘multifaceted’, believes that Women’s Month should be celebrated in order to pay homage to the phenomenal women who went before us. She highlights the importance of picking up where they left off. 

“I look forward to the day when being a woman simply means BEING.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept